Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.32 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.32 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.31 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.31 |
| ▸ | PSD | A5PKW4 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29295617 | 0.92 | MCL1 (0.36) | MCL1ACMSDPDK2ENPP3ENPP1 | |
| SCHEMBL26482163 | 0.92 | PDK2 (0.36) | ALOX5PDK2 | |
| SCHEMBL26859833 | 0.91 | PDK2 (0.34) | MCL1ACMSDPDK2ENPP3ENPP1 | |
| SCHEMBL26020023 | 0.89 | PDK2 (0.39) | MCL1ACMSDPDK2ENPP3ENPP1 | |
| SCHEMBL25577842 | 0.89 | PDK2 (0.39) | MCL1ACMSDPDK2ENPP3ENPP1 | |
| SCHEMBL23056799 | 0.88 | ENPP3 (0.32) | PDK2ENPP3ENPP1CA12CA1 | |
| SCHEMBL26482170 | 0.88 | PDK2 (0.38) | PDK2 | |
| SCHEMBL20365321 | 0.87 | PDK2 (0.34) | PDK2ENPP3ENPP1CA12CA1 | |
| SCHEMBL25580156 | 0.87 | PDK2 (0.39) | MCL1ACMSDPDK2ENPP3ENPP1 | |
| SCHEMBL29317026 | 0.87 | CA12 (0.40) | MCL1ACMSDPDK2ENPP3ENPP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230128708-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2023-04-27 | — | — | US | disclosed |
| US-20230128708-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230128708-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | PIEZO1, TMEM109, OXA1L | MCL1 2105/4885ACMSD 910/4885ALOX5 4031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.